| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2020 | Brege Laura62 | Director | Sale+OE | 10,000 | $42.19 | $421,900.00 | -100% | |
| Dec 12, 2019 | Yang Michael J. | EVP And CCO | Sale+OE | 105,479 | $44.46 | $4,689,262.89 | -91.3% | |
| Dec 11, 2019 | Kim Austin D.66 | EVP &General Counsel | Sale+OE | 17,500 | $45.06 | $788,576.25 | -97.2% | |
| Dec 9, 2019 | Yang Michael J. | EVP And CCO | Sale+OE | 14,521 | $50.46 | $732,792.26 | -68.3% | |
| Dec 9, 2019 | Ridloff Elena48 | EVP And CFO | Sale+OE | 36,000 | $49.66 | $1,787,853.45 | -44.7% | |
| Dec 5, 2019 | Davis Stephen68 | CEO | Sale+OE | 150,000 | $52.34 | $7,851,299.93 | -58.7% | |
| Nov 19, 2019 | Stankovic Srdjan R.62 | President | Sale+OE | 2,160 | $46.41 | $100,245.60 | -26.4% | |
| Oct 15, 2019 | Yang Michael J. | EVP And CCO | Sale+OE | 877 | $39.65 | $34,773.05 | -35.1% | |
| Oct 15, 2019 | Miller Eric Alejandro | Controller &Pao | Sale+OE | 147 | $39.65 | $5,828.55 | -35.3% | |
| Oct 15, 2019 | Davis Stephen68 | CEO | Sale+OE | 2,983 | $39.65 | $118,275.95 | -50.2% |